# reload+after+2024-01-23 04:31:52.109019
address1§1500 Broadway
address2§Suite 1401
city§New York
state§NY
zip§10036
country§United States
phone§332 208 6102
website§https://www.nuvationbio.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-868, a selective oral small molecule BET inhibitor that epigenetically regulates proteins that control tumor growth and differentiation, including oncogenes comprising c-myc; NUV-1156, an AR binder Xtandi that address advanced stage prostate cancers with the potential to move into earlier lines typically treated with surgical prostatectomy; and drug-drug conjugate (DDC) platform that focuses on targeting an inhibitor of poly ADP ribose polymerase (PARP) to anti-cancer warheads of existing drugs, as well as NUV-1176, a PARP inhibitor to address ER+ breast and ovarian cancer. Nuvation Bio Inc. was founded in 2018 and is headquartered in New York, New York.
fullTimeEmployees§53
companyOfficers§[{'maxAge': 1, 'name': 'Dr. David T. Hung M.D.', 'age': 65, 'title': 'Founder, President, CEO & Director', 'yearBorn': 1958, 'fiscalYear': 2022, 'totalPay': 944509, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. David C. Hanley Ph.D.', 'age': 53, 'title': 'Chief Technical Operations Officer', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 586040, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Moses  Makunje', 'age': 45, 'title': 'Principal Accounting Officer & Principal Financial Officer', 'yearBorn': 1978, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Gary  Hattersley Ph.D.', 'age': 56, 'title': 'Chief Scientific Officer', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 687881, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Stacy  Markel', 'age': 58, 'title': 'Chief People Officer', 'yearBorn': 1965, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Kerry A. Wentworth', 'age': 50, 'title': 'Chief Regulatory Officer', 'yearBorn': 1973, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. David  Liu M.D., Ph.D.', 'age': 53, 'title': 'Chief Medical Officer', 'yearBorn': 1970, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§7
boardRisk§7
compensationRisk§10
shareHolderRightsRisk§10
overallRisk§10
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.131
currency§USD
dateShortInterest§1702598400
forwardEps§-0.48
exchange§NYQ
quoteType§EQUITY
shortName§Nuvation Bio Inc.
longName§Nuvation Bio Inc.
firstTradeDateEpochUtc§1598448600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§292fc361-56ab-3994-b08a-1a4c45c2f81b
gmtOffSetMilliseconds§-18000000
targetHighPrice§5.0
targetLowPrice§1.4
targetMeanPrice§3.73
targetMedianPrice§4.25
recommendationMean§2.2
recommendationKey§buy
numberOfAnalystOpinions§4
quickRatio§38.554
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
